Randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients: an update based on 10 years' follow-up. German Breast Cancer Study Group.
第一作者:
W,Sauerbrei
第一单位:
Institute of Medical Biometry, University of Freiburg, Freiburg, Germany. wfs@imbi.unifreiburg.de
作者:
医学主题词
成年人(Adult);老年人(Aged);抗肿瘤药, 激素(Antineoplastic Agents, Hormonal);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);乳腺肿瘤(Breast Neoplasms);环磷酰胺(Cyclophosphamide);无病生存(Disease-Free Survival);女(雌)性(Female);氟尿嘧啶(Fluorouracil);随访研究(Follow-Up Studies);德国(Germany);人类(Humans);甲氨蝶呤(Methotrexate);中年人(Middle Aged);多元分析(Multivariate Analysis);存活率(Survival Rate);他莫昔芬(Tamoxifen);时间因素(Time Factors)
DOI
10.1200/JCO.2000.18.1.94
PMID
10623698
发布时间
2017-02-10
- 浏览11
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



